
A new study delves into the influence of preoperative glaucoma medications on the success of Schlemm's canal surgery. The study analyzed the medical records of 218 patients who underwent μTLO, a procedure for glaucoma, over one year. They found that medications not affecting conventional outflow pathways increased surgical risks. β-blockers and oral CAIs were notably linked to poorer outcomes. Success rates for β-blocker and oral CAI users were significantly lower compared to non-users, as confirmed by Kaplan–Meier survival curves. These findings underscore the importance of considering preoperative medication choices in glaucoma patients undergoing Schlemm's canal surgery.
Like
Save
Share